Tempest Therapeutics

(NASDAQ) TPST

Current Price$2.04

Market Cap$28.54M

Since IPO (2021)-99%

5 Year-99%

1 Year-72%

1 Month+21%

Tempest Therapeutics Financials at a Glance

Market Cap

$28.54M

Revenue (TTM)

$0.00

Net Income (TTM)

$26.26M

EPS (TTM)

$-6.84

P/E Ratio

-0.29

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Price

$2.04

Volume

2,886

Open

$2.02

Price

$2.04

Volume

2,886

Open

$2.02

Previous Close

$2.04

Daily Range

$2.00 - $2.09

52-Week Range

$1.50 - $12.23

Dividend

$0.00

Beta (Volatility)

1.63 (High)

Price

$2.04

Volume

2,886

Open

$2.02

Previous Close

$2.04

Daily Range

$2.00 - $2.09

52-Week Range

$1.50 - $12.23

TPST News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tempest Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Stephen R. Brady

Website

www.tempesttx.com

Headquarters

Brisbane, CA 94080, US

TPST Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-204%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-3.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.54M

Shares Outstanding

14.34M

Volume

2.89K

Avg. Volume

212.54K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$26.57M

EBITDA

$25.79M

Operating Cash Flow

$26.82M

Capital Expenditure

$0.00

Free Cash Flow

$26.82M

Cash & ST Invst.

$7.71M

Total Debt

$8.14M

Tempest Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$28.54M

N/A

Market Cap/Employee

$1.19M

N/A

Employees

N/A

Net Income

$4.02M

+70.9%

EBITDA

$3.96M

+70.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$434.00K

-102.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$6.95M

-14.7%

Short Term Debt

$1.19M

-83.5%

Return on Assets

-1.55%

N/A

Return on Invested Capital

-1.95%

N/A

Free Cash Flow

$24.50M

-141.4%

Operating Cash Flow

$24.50M

-141.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BRNSBarinthus Biotherapeutics plc

BRNSBarinthus Biotherapeutics plc$0.65+0.11%

FGENFibroGen, Inc.

FGENFibroGen, Inc.$9.07-1.63%

ALGSAligos Therapeutics, Inc.

ALGSAligos Therapeutics, Inc.$6.09+1.67%

INMBINmune Bio, Inc.

INMBINmune Bio, Inc.$1.51+5.59%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$8.32+5.05%

KZRKezar Life Sciences, Inc.

KZRKezar Life Sciences, Inc.$7.33+0.27%

PDSBPDS Biotechnology Corporation

PDSBPDS Biotechnology Corporation$0.98+0.79%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

MARAMara Holdings

MARAMara Holdings$11.46-0.04%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.84+0.01%

Questions About TPST

What is the current price of Tempest Therapeutics?

Tempest Therapeutics is trading at $2.04 per share.

What is the 52-week range for Tempest Therapeutics?

Over the past 52 weeks, Tempest Therapeutics has traded between $1.50 and $12.23.

How much debt does Tempest Therapeutics have?

As of the most recent reporting period, Tempest Therapeutics reported total debt of $8.14M.

How much cash does Tempest Therapeutics have on hand?

Tempest Therapeutics reported $7.71M in cash and cash equivalents in its most recent financial results.

What is Tempest Therapeutics’s dividend yield?

Tempest Therapeutics does not currently have a dividend yield.

Tempest Therapeutics

Tempest Therapeutics Financials at a Glance

TPST News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Tempest Therapeutics

TPST Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Tempest Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TPST

What is the current price of Tempest Therapeutics?

What is the 52-week range for Tempest Therapeutics?

How much debt does Tempest Therapeutics have?

How much cash does Tempest Therapeutics have on hand?

What is Tempest Therapeutics’s dividend yield?

Premium Investing Services